We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+6.42%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
AUM
$1.45B
AUM Growth
+$336M
Cap. Flow
+$603M
Cap. Flow %
41.48%
Top 10 Hldgs %
67.23%
Holding
768
New
375
Increased
70
Reduced
59
Closed
238

Sector Composition

Rank Sector Weight
1 Healthcare 11.15%
2 Financials 9.75%
3 Technology 2.87%
4 Industrials 2.67%
5 Consumer Discretionary 1.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BWACW
176
DELISTED
BETTER WORLD ACQUISITION CORP. Warrants
BWACW
$564K 0.04%
+541,943
New +$823K
TVRD
177
Tvardi Therapeutics
TVRD
$22M
$562K 0.04%
+719
New +$492K
QELL
178
DELISTED
Qell Acquisition Corp. Class A Ordinary Shares
QELL
$559K 0.04%
+54,901
New +$666K
ASAQ.WS
179
DELISTED
Atlantic Avenue Acquisition Corp Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
ASAQ.WS
$557K 0.04%
752,216
+702,216
+1,404% +$854K
SEAH.WS
180
DELISTED
Sports Entertainment Acquisition Corp. Redeemable Warrants, each whole Warrant exercisable for one s
SEAH.WS
$552K 0.04%
501,820
+471,820
+1,573% +$729K
TERN
181
DELISTED
Terns Pharmaceuticals
TERN
$550K 0.04%
+25,000
New +$548K
ARGX icon
182
argenx
ARGX
$54.2B
$544K 0.04%
+1,975
New +$624K
GE icon
183
PUT
GE Aerospace
GE
$380B
$540K 0.04%
+147,006
New +$8.9M
VTIQW
184
DELISTED
VectoIQ Acquisition Corp. II Warrant
VTIQW
$533K 0.04%
+372,628
New +$719K
VLDR
185
PUT
DELISTED
Velodyne Lidar, Inc. Common Stock
VLDR
$526K 0.04%
+94,200
New +$1.77M
PS
186
CALL
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
$510K 0.04%
273,300
+201,600
+281% +$4.32M
UTHR icon
187
CALL
United Therapeutics
UTHR
$22.7B
$500K 0.03%
10,500
GOAC.WS
188
DELISTED
GO Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock
GOAC.WS
$499K 0.03%
554,698
+490,412
+763% +$743K
CYXT
189
DELISTED
Cyxtera Technologies, Inc. Class A Common Stock
CYXT
$497K 0.03%
+50,000
New +$524K
THCX
190
DELISTED
AXS Cannabis ETF
THCX
$492K 0.03%
2,500
-5,000
-67% -$980K
DLCA
191
DELISTED
Deep Lake Capital Acquisition Corp. Class A Ordinary Shares
DLCA
$490K 0.03%
+50,000
New +$489K
HUMAW icon
192
Humacyte Inc Warrant
HUMAW
$1.38M
$487K 0.03%
167,525
+122,525
+272% +$290K
CND.WS
193
DELISTED
Concord Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
CND.WS
$471K 0.03%
+523,030
New +$701K
KIIIU
194
DELISTED
Kismet Acquisition Three Corp. Unit
KIIIU
$464K 0.03%
+47,009
New +$470K
DSKEW
195
DELISTED
Daseke, Inc. Warrant
DSKEW
$455K 0.03%
1,340,298
-328,002
-20% -$69.9K
BSX icon
196
PUT
Boston Scientific
BSX
$73.1B
$448K 0.03%
+209,800
New +$7.94M
SVSVW
197
DELISTED
Spring Valley Acquisition Corp. Warrant
SVSVW
$434K 0.03%
+364,391
New +$700K
NRDY icon
198
Nerdy
NRDY
$93.5M
$423K 0.03%
+42,647
New +$465K
EXEEZ
199
DELISTED
Expand Energy Corp Class B Warrants
EXEEZ
$422K 0.03%
+21,383
New +$426K
ALXN
200
PUT
DELISTED
Alexion Pharmaceuticals
ALXN
$422K 0.03%
48,500
+16,500
+52% +$2.55M

Similar funds

Cowen and Company's Q1 2021 Portfolio in Review

As of Q1 2021, Cowen and Company held 768 positions worth $1.45B, up 30% from $1.12B the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Cowen and Company deployed $603M of net new capital in Q1 2021, opening 375 new positions and adding to 70 existing holdings. Its largest new stake was iTeos Therapeutics: 588,238 shares worth $20.1M.

By sector, the portfolio is most concentrated in Healthcare at 11% of assets, up from 4.9% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Freeport-McMoran, an estimated $5.42M trimmed.

  • Cowen and Company's largest Q1 2021 buy was iTeos Therapeutics: 588,238 shares worth $20.1M.
  • Cowen and Company added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q1 2021, an estimated $151M increase.
  • Cowen and Company's biggest Q1 2021 reduction was Freeport-McMoran, cutting an estimated $5.42M.
  • Cowen and Company fully exited VanEck Semiconductor ETF in Q1 2021, selling an estimated $30.8M.
  • Cowen and Company's ten largest holdings make up 67% of its $1.45B portfolio in Q1 2021.
  • Cowen and Company opened 375 new positions and closed 238 in Q1 2021.
  • Cowen and Company's portfolio value rose 30% quarter-over-quarter to $1.45B.

Based on Cowen and Company's 13F filing for Q1 2021, filed 4 May 2021.